LivaNova (LIVN) EPS (Weighted Average and Diluted) (2014 - 2026)
LivaNova recorded quarterly EPS (Weighted Average and Diluted) of $0.4 in Q1 2026, down 28.57% quarter-over-quarter from $0.56 in Q4 2025, and up 106.66% year-over-year from $0.19 in Q1 2025.
LivaNova's EPS (Weighted Average and Diluted) history runs 13 years deep, the most recent figure standing at $0.4 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 106.66% year-over-year to $0.4; the TTM figure through Mar 2026 stood at $1.95 (up 147.79% YoY), while the FY2025 annual figure was -$4.45, down 483.62% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.4 for Q1 2026 at LivaNova, down from $0.56 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.03 in Q4 2024 to a low of -$6.01 in Q1 2025.
- A 5-year average of -$0.25 and a median of $0.3 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) soared 1400.0% in 2024 and slumped 670.51% in 2025, its largest moves.
- LivaNova's EPS (Weighted Average and Diluted) stood at $0.03 in 2022, then surged by 900.0% to $0.3 in 2023, then jumped by 243.33% to $1.03 in 2024, then sank by 45.63% to $0.56 in 2025, then declined by 28.57% to $0.4 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.4, $0.56, and $0.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.56 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.50 |
| Mar 31, 2025 | -6.01 |
| Dec 31, 2024 | 1.03 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.30 |
| Mar 31, 2024 | -0.78 |
| Dec 31, 2023 | 0.30 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.14 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | -2.01 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.84 |
| Jun 30, 2021 | -1.15 |
| Mar 31, 2021 | -0.63 |
| Dec 31, 2020 | -5.78 |
| Sep 30, 2020 | -0.30 |
| Jun 30, 2020 | -1.84 |
| Mar 31, 2020 | 0.77 |
| Dec 31, 2019 | -2.96 |
| Sep 30, 2019 | 0.66 |
| Jun 30, 2019 | -0.60 |
| Mar 31, 2019 | -0.31 |
| Dec 31, 2018 | -4.34 |
| Sep 30, 2018 | -0.15 |
| Jun 30, 2018 | 0.31 |
| Mar 31, 2018 | 0.36 |
| Dec 31, 2017 | -2.32 |
| Sep 30, 2017 | 0.57 |
| Jun 30, 2017 | 0.95 |
| Mar 31, 2017 | 0.27 |
| Dec 31, 2016 | -0.61 |
| Sep 30, 2016 | 0.13 |
| Jun 30, 2016 | 0.26 |
| Mar 31, 2016 | -0.83 |
| Dec 31, 2015 | -0.45 |
| Oct 18, 2015 | -0.96 |
| Jul 24, 2015 | 0.47 |
| Apr 24, 2015 | 0.40 |
| Dec 26, 2014 | 0.16 |
| Oct 24, 2014 | 0.64 |
| Apr 25, 2014 | 0.40 |